Women's health: 8 weeks on CJC-1295/Ipamorelin and AOD-9604
I wanted to share my experience as I hit the 8-week mark on my current protocol. I’m taking 100mcg of CJC-1295/Ipamorelin at night and 300mcg of AOD-9604 in the morning. My primary goal was body composition and energy levels. The results have been subtle but consistent. My HRV has improved from a baseline of 35ms to 52ms, which is a huge win for my recovery and stress management. I’ve lost about 4 pounds of stubborn fat, mostly around my midsection, which hasn't budged in years despite strict dieting. I’m feeling much more energized during my morning workouts. Has anyone else experienced this kind of shift in their HRV data? I’m curious if the Ipamorelin is the main driver here or if the metabolic support from the AOD is playing a bigger role than I thought. Looking forward to hearing how other women are finding this stack.
It is fantastic to hear you are seeing such positive objective data with your HRV improvement. That significant jump from 35ms to 52ms is a strong indicator that the CJC-1295/Ipamorelin combo is effectively optimizing your pulsatile growth hormone secretion, which directly enhances autonomic nervous system regulation. Many users overlook sleep quality as a primary driver for body composition, but the nocturnal GH boost from this protocol is likely facilitating better restorative sleep, allowing your body to move out of a sympathetic-dominant state. Regarding the AOD-9604, targeting lipolysis by mimicking the fat-reducing domain of the GH molecule is a smart strategy for that stubborn adipose tissue that often resists standard caloric restriction. Since you are hitting the 8-week mark, keep a close eye on your fasting insulin levels, as some users find that optimizing these pathways can improve metabolic flexibility over time. Always remember to maintain consistent hydration and electrolyte intake to support the metabolic shifts your body is undergoing. Keep up the disciplined routine and please keep us updated on your progress as you push into the next phase of your protocol.